Big pharma, Insight journal - Dealtalk

M&A news: Watson aim to acquire Actavis by April

Posted on 13 April 2012

Tags: , , , ,

Watson Pharmaceuticals Inc is on track to announce a M&A deal to buy Actavis for around $6 billion by the end of April, creating one of the world's biggest producers of generic drugs, sources familiar with the matter said on Wednesday.

While negotiations are complex, there are no major hurdles in sight that would stop the two sides from reaching M&A agreement, two people briefed on the situation said.

Reuters first reported on March 21 that Watson was close to buying Actavis, an unlisted Swiss-based firm, in a potential 5.0-5.5 billion euros ($6.5-7.2 billion) deal. Since then some sources have said the price may be nearer 4.5 billion euros.

Read the full article at Reuters



Read: more on dealtalk in pharma, biotech, life science partnering deal news, insights and glossary

Read: Big pharma deal news - latest deal news for top 50 pharma / big pharma companies

Report: Merger and Acquisition Terms and Agreements

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply